« go back
SynBioBeta early bird registration ends 5 February
April 6th - 8th, at Imperial College London, UK
SynBioBeta London 2016 brings together some of the brightest minds from the worlds of synthetic biology, biotech, and biopharma. With a program full of talks from over 40 key thought-leaders, decision makers, and tech pioneers, SynBioBeta is a must for those wanting to keep up with the rapidly-evolving industry.
Some of the Key Session and Panel Topics Include:
- The Application Stack: No one knows what the future will bring, but this session will give you a pretty good idea. Covering the present and future of synthetic biology, tackling problems from food, vitamins, information storage, to high-value molecule fermentation for the production of biofuels and specialty chemicals. Our speakers will give an insight into the bleeding edge of innovation.
- Synthetic Biology for Biopharmaceuticals: Synthetic Biology offers the potential to revolutionize many industries, but the one at the front both in terms of opportunity, ability to do good, and market size is the production of bio-based pharma and cell therapies. In this session, you’ll learn about T-cell receptors, CRISPR/Cas9 screening for cancer-causing mutations and other applications of synthetic biology for making people better.
- Robotics and Hardware for Synthetic Biology: Speed, reproducibility, efficiency, and value. Robotics allows experiments to be performed quickly and reproducibly, cloud systems let scientists outsource the actual process of experimentation, and machine learning offers the potential for automated data analysis and creation of hypothesis. What changes will these technologies bring, how will they affect synthetic biology, and who are the leaders in bringing it to market? Come along and find out in this session.
- Engineering the Microbiome: The human microbiome is the community of microbes that colonize the human body. This has been an exciting area of growth over the past decade. In recent years, a number of companies have made advances in the engineering of these microbes for new applications. In this session, we will hear from companies engineering and undertaking genetic engineering to make antimicrobials using CRISPR/Cas9, personal care products, like sunscreens to provide UV protection, or engineering gut bacteria to combat metabolic disease.
- Investor Roundtables: Without investment, no biotech company could ever get off the ground. But what are investors looking for? What is the best stage to raise capital, and who should you be talking to? What are the global trends in synthetic biology investment and how will they affect the industry? Whether you are an entrepreneur with a plan, an investor with a checkbook, or a CEO with acquisition plans, this is the panel for you.
Networking opportunities are rich for those aiming to grow their company, their client list, or launch their next product – many a fruitful partnership, connection, or new venture has been started at SynBioBeta conferences. If you are an active part of the synthetic biology industry and have a passion for making biology easier to engineer, then this is a must attend event.